Liquidia (NASDAQ:LQDA) CEO Roger Jeffs Sells 25,000 Shares
by Amy Steele · The Cerbat GemLiquidia Corporation (NASDAQ:LQDA – Get Free Report) CEO Roger Jeffs sold 25,000 shares of the business’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $42.09, for a total value of $1,052,250.00. Following the transaction, the chief executive officer owned 1,348,095 shares in the company, valued at approximately $56,741,318.55. This trade represents a 1.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Roger Jeffs also recently made the following trade(s):
- On Tuesday, May 5th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.10, for a total value of $1,002,500.00.
- On Friday, April 17th, Roger Jeffs sold 18,839 shares of Liquidia stock. The stock was sold at an average price of $40.60, for a total value of $764,863.40.
- On Wednesday, April 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.14, for a total value of $1,003,500.00.
- On Tuesday, April 14th, Roger Jeffs sold 3,300 shares of Liquidia stock. The stock was sold at an average price of $40.00, for a total value of $132,000.00.
- On Monday, April 13th, Roger Jeffs sold 32,744 shares of Liquidia stock. The stock was sold at an average price of $38.37, for a total value of $1,256,387.28.
- On Friday, April 10th, Roger Jeffs sold 21,433 shares of Liquidia stock. The stock was sold at an average price of $40.12, for a total value of $859,891.96.
- On Thursday, April 9th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.12, for a total value of $1,003,000.00.
Liquidia Stock Up 0.3%
Shares of LQDA stock opened at $42.28 on Friday. Liquidia Corporation has a 1-year low of $11.85 and a 1-year high of $46.67. The stock’s fifty day moving average price is $36.96 and its 200 day moving average price is $34.71. The company has a debt-to-equity ratio of 2.97, a current ratio of 2.01 and a quick ratio of 1.84. The company has a market cap of $3.76 billion, a price-to-earnings ratio of -50.94 and a beta of 0.41.
Liquidia (NASDAQ:LQDA – Get Free Report) last announced its earnings results on Thursday, March 5th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.07. Liquidia had a negative return on equity of 209.33% and a negative net margin of 43.53%.The firm had revenue of $92.02 million for the quarter, compared to the consensus estimate of $87.49 million. The firm’s revenue for the quarter was up 3072.4% on a year-over-year basis. On average, research analysts expect that Liquidia Corporation will post 1.75 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Several analysts have weighed in on LQDA shares. Zacks Research upgraded Liquidia from a “hold” rating to a “strong-buy” rating in a research note on Tuesday. Wall Street Zen upgraded Liquidia from a “hold” rating to a “buy” rating in a research note on Saturday, March 7th. Jefferies Financial Group boosted their price target on Liquidia from $45.00 to $55.00 and gave the company a “buy” rating in a research note on Tuesday, January 13th. HC Wainwright boosted their price target on Liquidia from $50.00 to $55.00 and gave the company a “buy” rating in a research note on Friday, March 6th. Finally, Needham & Company LLC boosted their price target on Liquidia from $52.00 to $54.00 and gave the company a “buy” rating in a research note on Thursday, March 5th. Three equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $43.44.
Read Our Latest Analysis on Liquidia
Institutional Trading of Liquidia
Large investors have recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. acquired a new position in shares of Liquidia in the 4th quarter valued at about $25,000. NewEdge Advisors LLC acquired a new position in shares of Liquidia in the 2nd quarter valued at about $25,000. Skandinaviska Enskilda Banken AB publ acquired a new position in shares of Liquidia in the 3rd quarter valued at about $30,000. FNY Investment Advisers LLC acquired a new position in shares of Liquidia in the 3rd quarter valued at about $34,000. Finally, Covestor Ltd lifted its holdings in shares of Liquidia by 41.9% in the 4th quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after buying an additional 359 shares during the period. Hedge funds and other institutional investors own 64.54% of the company’s stock.
Liquidia Company Profile
Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.
The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).